Last €60.19 EUR
Change Today -0.75 / -1.23%
Volume 100.0
JUD On Other Exchanges
New York
As of 1:40 PM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

st jude medical inc (JUD) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/2/15 - €61.46
52 Week Low
10/15/14 - €44.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ST JUDE MEDICAL INC (JUD)

st jude medical inc (JUD) Related Businessweek News

View More BusinessWeek News

st jude medical inc (JUD) Details

St. Jude Medical, Inc., together with its subsidiaries, develops, manufactures and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide. It operates in two divisions, Implantable Electronic Systems, and Cardiovascular and Ablation Technologies. The company offers tachycardia implantable cardioverter defibrillator systems and cardiac resynchronization therapy defibrillator devices to treat patients suffering from lethal heart conditions, such as sudden cardiac arrest or heart failure. It also provides pacemakers, which deliver low-voltage electrical impulses to stimulate a heartbeat for patients whose hearts beat too slowly; and atrial fibrillation products comprising electrophysiology, introducers and catheters, advanced cardiac mapping, navigation and recording systems, and ablation systems. In addition, the company offers vascular closure devices, compression assist devices, pressure measurement guidewires, diagnostic coronary imaging technology, percutaneous catheter introducers, diagnostic guidewires, renal denervation technology and vascular plugs, optical coherence tomography imaging products, and other vascular accessories, as well as CardioMEMS, a heart failure monitoring device. Further, it provides structural heart products, including transcatheter aortic heart valves, various surgical heart valve repair and replacement products, and transcatheter structural heart defect devices; and neuromodulation products, such as spinal cord stimulation and radiofrequency ablation to treat chronic pain, as well as deep brain stimulation to treat movement disorders. The company sells its products through direct sales force and independent distributors. St. Jude Medical, Inc. was founded in 1976 and is headquartered in St. Paul, Minnesota.

16,000 Employees
Last Reported Date: 02/26/15
Founded in 1976

st jude medical inc (JUD) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $1.0M
Chief Financial Officer and Vice President of...
Total Annual Compensation: $430.0K
Chief Operating Officer
Total Annual Compensation: $730.0K
President of International Division
Total Annual Compensation: $752.4K
Executive Vice President
Total Annual Compensation: $730.0K
Compensation as of Fiscal Year 2013.

st jude medical inc (JUD) Key Developments

St. Jude to Pay $14.5 Million to Settle Riata Lawsuits

St. Jude Medical Inc. could pay up to $14.5 million to settle claims over its malfunctioning Riata defibrillator wires. Minnesota Public Radio reports on the disclosure by the med-tech company. It stopped selling the Riata leads in 2010 as reports surfaced the wires were decaying early and breaking through insulation. Faulty defibrillator wires can result in shocking users at the wrong times, or failing to operate when the patient's heart stops.

St. Jude Medical Seeks Acquisitions

St. Jude Medical Inc. (NYSE:STJ) is seeking acquisitions. St. Jude Medical has shifted focus to strategic acquisitions and agreements as its key business strategies to increase its share in the Saudi Arabia, South Africa, and Turkish neuromodulation market.

St. Jude Medical, Inc. Declares Quarterly Dividend, Payable April 30, 2015

St. Jude Medical Inc. announced that its board of directors declared a 7% increase in the company's quarterly dividend to $0.29 per common share. The dividend is payable April 30, 2015, to shareholders of record on March 31, 2015. At the new rate, the annual dividend would be $1.16 per share, compared to the previous annual dividend of $1.08 per share.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JUD:GR €60.19 EUR -0.75

JUD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Boston Scientific Corp $16.76 USD -0.30
Coloplast A/S kr519.50 DKK -11.50
Smith & Nephew PLC 1,131 GBp -68.00
Terumo Corp ¥3,250 JPY -45.00
Zimmer Holdings Inc $119.27 USD -2.12
View Industry Companies

Industry Analysis


Industry Average

Valuation JUD Industry Range
Price/Earnings 19.3x
Price/Sales 3.4x
Price/Book 4.6x
Price/Cash Flow 17.2x
TEV/Sales 2.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ST JUDE MEDICAL INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at